 |
9th Annual CTSI Translational Science Symposium
In Memory of David Seldin, MD, PhD (1957-2015)
Feb. 24, 2021, 8 a.m. - 1 p.m.
|
Race & Research: Old Challenges, New Approaches
Society is increasingly seeking answers about the role and impact that racism and structural oppression play in every facet of medical research conducted in the US. This year, the CTSI has chosen to fashion our 2021 CTSI Symposium as a fresh opportunity for the BUMC/BMC/BU research community to ponder these questions, challenges, and the difficult decisions associated with this focus. We will discuss novel approaches to provide better designed anti-racist research. You will learn from fellow researchers who have thoughtfully and rigorously applied anti-racist principles to engage in clinical and translational medical research. Our symposium has been designed to provide a safe, opportunity for you to think deeper about these essential issues and to challenge yourself to participate with your peers and colleagues in an open, honest and non-judgmental but challenging dialogue about race and research. We sincerely hope you can join us! Visit Our Webpage
EVENT HOST: Christopher W. Shanahan, MD, MPH, FACP
View the Draft Symposium Agenda Here.
|
|
|
|
|
The KL2 program is a mentored career development program for BU's most promising junior faculty translational researchers. This program is committed to increasing the diversity of the research workforce and strongly encourages applications from underrepresented, racial, and ethnic groups (UREGs).
|
|
|
|
Presented at 12 p.m. by: William G. Adams, MD, Kimberly Ann Dukes, PhD, & Heather Hsu, MD, MPH. This 2nd presentation focuses on the "Use of Large Data Sets to Facilitate Research with Underrepresented Groups", which is build upon earlier presentations on research regulatory considerations related to vulnerable subjects. Read More
|
|
|
|
|
Now Accepting Registrations!
All mentoring faculty are encouraged to register for these 5 Mentoring Sessions
An interactive training program that uses case studies developed and vetted with other Clinical & Translational Science Institutes around the country.This is a great opportunity to interact with and learn from colleagues in other disciplines. A certificate will be supplied to include in your training grant applications. Read More
|
|
|
|
The BU CTSI Team Science/IBRO/Evans Center IBR, under the directorship of
Dr. Katya Ravid, is pleased to announce the 2021 ARC Profiles booklet!
Take a look at Affinity Research Collaboratives’s (ARC’s) Linking Research and Researchers booklet and explore their novel interdisciplinary approaches to and impacts on both biomedical research and training.
|
|
|
|
|
ACME POCT 2021 Call for Pilot Proposals: Microfluidics/Lab-on-a-Chip Point-of-Care Technologies |
Our priority for the 2021 call for applications is to fund clinically relevant microfluidics-based proposals for devices that have already been through some level of investment in research, development, evaluation, or clinical validation but have been unable to progress due to a significant and definable barrier that can be resolved through additional funds and/or targeted expertise in engineering, regulatory, or other type of specific expert contribution. Pre-Proposals due date: Mar.1, 20201. Read the Funding Announcement
|
|
|
|
2021 Award Competition: Center for Advancing Point of Care Technologies in Heart, Lung, Blood and Sleep Disorders – Funding Opportunity |
The Center for Advancing Point of Care Technologies (CAPCaT) in Heart, Lung, Blood, and Sleep Disorders announces the 2021 solicitation of grant applications focused on developing, adapting, or validating point of care technologies that can be rapidly applied to heart, lung, blood, or sleep disorders, with additional interest in projects that incorporate complementary and integrative health approaches. The LOI due date: Mar.1, 2021.
|
|
|
|
|
2021 Award Competition: Development of Point-Of-Care Testing for HIV and Co-Morbidities for Use in Low and Middle Income Countries |
We support projects designed for settings with limited medical infrastructure. Relevant projects considered for funding include, but are not limited to, diagnostic assays or technologies for HIV/AIDS disease and its comorbidities, treatment-related diagnostics, and technologies. Pre-Proposals due date: Mar.1, 20201. Read the Funding Announcement
|
|
|
|
Johns Hopkins University Center for Point of Care Technologies Research for Sexually Transmitted Diseases |
The Johns Hopkins University Center for Point of Care Technologies Research for Sexually Transmitted Diseases (STDs) will not be issuing a solicitation in 2021. Instead, our Center is approaching companies who submitted applications for COVID diagnostics to gauge their interest in pivoting their platforms
to the detection of STDs.
|
|
|
|
|
Study Introduces mRNA-LNP as a Safe Therapeutic Intervention for Liver Regeneration
A new study led by researchers at the Center for Regenerative Medicine at Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) describes a safe new potential therapeutic tool for the recovery of liver function in chronic and acute liver diseases. Read More
|
|
|
|
|
BU Researchers Identify Genetic Dependencies in Tumors that have Undergone Whole Genome Doubling
Researchers from Boston University School of Medicine (BUSM) have identified proteins that are essential for the viability of whole-genome doubled tumor cells, yet non-essential to normal cells that comprise the majority of human tissue. Read More
|
|
|
|
|
Pfizer and Moderna Haven't Proven their COVID-19 Vaccines Shield Against New Variants: Analysts
Just as the U.S. government purchases Pfizer’s and Moderna’s mRNA vaccines to prevent COVID-19, a troubling question is emerging in the scientific community: Can these shots protect people against aggressive new variants racing through the U.K., South Africa, and Brazil? Read More
|
|
|
|
|
Cancer Drug Derived from Sea Squirts Outperforms Remdesivir in COVID-19 Preclinical Models
The search among existing drugs for potential COVID-19 treatments has pointed to another promising candidate—a cancer drug that appears to perform better than Gilead Sciences’ FDA-approved remdesivir against the SARS-CoV-2 virus behind the disease. Read More
|
|
|
|
|
Why it Takes 2 Shots to Make mRNA Vaccines Do their Antibody-Creating Best – and What the Data Shows on Delaying the Booster Dose
With the U.S. facing vaccination delays because of worker shortages and distribution problems, federal health officials now say it’s OK to push back the second dose of the two-part vaccine by as much as six weeks. Read More
|
|
|
|
|
NIMHD Health Disparities Research Institute Virtual Course
Aug. 9 -13, 2021
For Open Application Cycle:
Feb. 1, 2021, 9:00 a.m. ET
to Mar. 8, 2021, 5:00 p.m. ET.
Lecture and seminar topics will focus on the etiology of health disparities, methods and measurement, and intervention and implementation research. More Details Here
|
|
|
|
|
Deciphering the Response of Bone Cells To Bisphosphonates and Phosphate
Feb. 10, 2021, 12 - 1 p.m.
The Department of Translational Dental Medicine is holding a seminar, presented by Dr. Lauren Surface, Research Fellow, Michael Mannstadt Laboratory, Massachusetts General Hospital, and Instructor of Medicine, Harvard Medical School. Join the Zoom here. Meeting ID: 989 6066 4463. Passcode: 312601
|
|
|
|
|
18th Annual Winter Lung Cancer Conference, Feb. 5 - 7, 2021.
We are pleased to invite you to the upcoming 18th Annual Winter Lung Cancer Conference, a first-class continuing medical education event for the treatment of patients with lung cancer.
|
|
|
|
|
Educators Collab: Applying Theories
of Change to Measure Learning and Impact. Feb. 23, 2021, 12 - 1 p.m.
Dr. Sarah Hokanson, Assist. Provost of Professional Development & Postdoctoral Affairs presents: Massive Open Online Courses (MOOCs) have gained traction as resources for professional development, in addition to a solution to pandemic learning constraints. More Details Here.
|
|
|
|
|
Why and How We Study Racial
Health Disparities
Feb. 25, 2021, 4:30 - 6 p.m.
This series of panels will examine how race and racial health disparities are studied in epidemiology. The first panel in our series will explore the history of census data, how data on race are collected and studied, and the implications of how this data is used in population health science. More Details Here
|
|
|
|
|
|
Accelerating Discoveries Towards Better Health
|
bu.edu/ctsi | ncats.nih.gov
|
|
|
|
|
|
|
